These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 197571)

  • 21. Arachidonic acid elicits endothelium-dependent release from the rabbit aorta of a constrictor prostanoid resembling prostaglandin endoperoxides.
    Pagano PJ; Lin L; Sessa WC; Nasjletti A
    Circ Res; 1991 Aug; 69(2):396-405. PubMed ID: 1907227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1975 Jun; 94(2):222-8. PubMed ID: 1155178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.
    Smith JB; Ingerman C; Silver MJ
    J Clin Invest; 1976 Nov; 58(5):1119-22. PubMed ID: 993335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
    Miller OV; Johnson RA; Gorman RR
    Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1977; 14(6):1043-53. PubMed ID: 601247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
    Vargaftig BB; Chignard M
    Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.
    Higgs GA; Bunting S; Moncada S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):749-57. PubMed ID: 981700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.
    Needleman P; Raz A; Ferrendelli JA; Minkes M
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1716-20. PubMed ID: 193113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
    Burch JW; Burch PT
    Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
    Raz A; Aharony D
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV; Ayer DE; Gorman RR
    Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral arterial smooth muscle contraction by thromboxane A2.
    Ellis EF; Nies AS; Oates JA
    Stroke; 1977; 8(4):480-3. PubMed ID: 898244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.
    Yoshimoto T; Yamamoto S; Hayaishi O
    Prostaglandins; 1978 Oct; 16(4):529-40. PubMed ID: 725083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazole: a selective inhibitor of thromboxane synthetase.
    Moncada S; Bunting S; Mullane K; Thorogood P; Vane JR; Raz A; Needleman P
    Prostaglandins; 1977 Apr; 13(4):611-8. PubMed ID: 558637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets.
    Gryglewski RJ; Zmuda A; Dembińska-Kieć A; Krecioch E
    Pharmacol Res Commun; 1977 Feb; 9(2):109-16. PubMed ID: 866363
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.